QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer — Sep 10th, 2024

Lee Bowman, Chief Human Resources Officer, QuidelOrtho (Photo: Business Wire) SAN DIEGO, September 10, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) is pleased to announce the appointment of Lee Bowman as Chief Human Resources Officer (CHRO). In this pivotal role, Bowman l...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho Announces New R&D Executive Leader — Oct 9th, 2024

Jonathan Siegrist, EVP of R&D and CTO, QuidelOrtho (Photo: Business Wire) Jonathan Siegrist appointed as EVP of R&D and CTO SAN DIEGO, October 09, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in innovative diagnostic solutions, is pleased to announce the...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...

QuidelOrtho to Report Third Quarter 2024 Financial Results — Oct 17th, 2024

SAN DIEGO, October 17, 2024--(BUSINESS WIRE)--QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, announced today that it will ...

QuidelOrtho Insider Ups Holding By 54% During Year — Oct 9th, 2024

Looking at QuidelOrtho Corporation's (NASDAQ:QDEL ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold. While insider transactions are not the most important thing when it ...